<DOC>
	<DOCNO>NCT02424201</DOCNO>
	<brief_summary>Postpartum haemorrhage lead cause maternal haemorrhage globally . With active management labour 3 16.5 % parturients still experience postpartum haemorrhage . Hence need effective oxytocic third stage labour .</brief_summary>
	<brief_title>Comparative Study Effects Sublingual Misoprostol Addition Standard AMTSL Low Risk Parturients LASUTH , Ikeja .</brief_title>
	<detailed_description>This prospective randomize doubleblind control trial involve 660 consent pregnant woman . Eligible subject ransomised 2 group 330 participant . All patient receive standard oxytocin 10 unit part active management third stage labour . However , study group administer sublingual 400 misoprostol control group receive 2tablets placebo ( vitamin c ) . Measured mean blood loss comparee 2 group use statistical analysis .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>singleton longitudinal lie cephalic presentation refusal consent , multiple gestation</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>uterine atony</keyword>
</DOC>